Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure

Controlled human challenge trials of SARS-CoV-2 vaccine candidates could accelerate the testing and potential rollout of efficacious vaccines. By replacing conventional phase 3 testing of vaccine candidates, such trials may subtract many months from the licensure process, making efficacious vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales: Eyal, Nir, Lipsitch, Marc, Smith, Peter G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184325/
https://www.ncbi.nlm.nih.gov/pubmed/32232474
http://dx.doi.org/10.1093/infdis/jiaa152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184325/
https://www.ncbi.nlm.nih.gov/pubmed/32232474
http://dx.doi.org/10.1093/infdis/jiaa152

Ejemplares similares